Notify me when Saturn V Capital Management LP files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| XFOR | X4 Pharmaceuticals, Inc. | Common Stock | 7.4% | $25,026,241 | 6,433,481 | Saturn V Capital Management LP | 24 Oct 2025 | ||
| IMMX | Immix Biopharma, Inc. | Common Stock | 7% | $17,987,759 | 3,693,585 | Saturn V Capital Management LP | 26 Dec 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|